NCT03286049

Brief Summary

Longitudinal, observational study to assess the short-term (test re-test) and mid-term (within the span of 28 days) repeatability of active anterior rhinomanometry (AAR) measures on 4 parallel groups of children with different rhinitis phenotypes, and 1 group of control (healthy) children. Secondary objectives are: i) assessing of association between AAR, exhaled FeNO (eFeNO) and nasal FeNO (nFeNO); ii) assessing association between objective measurements (AAR, eFeNO and nFeNO) and subjective measurements (Total 5 Symptom score, T5SS). The study is intended to obtain useful information for improving rhinitis management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 18, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

January 10, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2018

Completed
Last Updated

November 16, 2018

Status Verified

November 1, 2018

Enrollment Period

7 months

First QC Date

September 5, 2017

Last Update Submit

November 15, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Short term repeatability of active anterior rhinomanometry (AAR)

    For each individual, it will be calculated the coefficient of variation of 5 measurements of AAR taken within 30 minutes, at baseline.

    1 day

  • Mid term repeatability of active anterior rhinomanometry (AAR)

    For each individual, it will be calculated the coefficient of variation of 3 measurements of AAR taken at baseline and then twice more within the span of 28 days (after one week and after two weeks).

    28 days

Secondary Outcomes (4)

  • Correlation between AAR and oral FeNO

    28 days

  • Correlation between AAR and nasal FeNO

    28 days

  • Correlation between AAR (objective perspective) and T5SS (subjective perspective)

    28 days

  • Correlation between FeNO (objective perspective) and T5SS (subjective perspective)

    28 days

Study Arms (5)

Healthy children (HC)

10 healthy children

Children with non allergic rhinitis (NAR)

10 children with non allergic rhinitis

Rhinitis children, perennial allergy (PAR)

10 rhinitis children, sensitized to perennial allergens

Rhinitis children, seasonal allergy, outside season (OSR)

10 rhinitis children sensitized to seasonal allergens, observed outside the allergen season

Rhinitis children, seasonal allergy, within season (WSR)

10 rhinitis children sensitized to seasonal allergens, observed during the allergen season

Eligibility Criteria

Age10 Years - 16 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

A study population of 40 rhinitis children (10 for each of 4 different rhinitis phenotypes) attending the outpatient clinic of Pediatric Allergology \& Pulmonology (PAP) within the Institute of Biomedicine and Molecular Immunology (IBIM) of the National Research Council (CNR) of Palermo (IBIM CNR), and a control group of 10 healthy volunteers.

You may qualify if:

  • Negative bronchodilator response;
  • No major nasal septum malformations.

You may not qualify if:

  • Upper airway infections in the previous 4 weeks;
  • Active smoker;
  • Lifetime history of asthma, rhinitis, or respiratory disease symptoms.
  • Children with non allergic rhinitis (NAR)
  • T5SS\>5 in the last 4 weeks.
  • At least one positive skin prick test for aeroallergens;
  • Upper airway infections in the previous 4 weeks;
  • Active smoker;
  • Major nasal septum malformations.
  • Rhinitis children, perennial allergy (PAR)
  • T5SS\>5 in the last 4 weeks.
  • At least one positive skin prick test for perennial aeroallergens;
  • At least one positive skin prick test for seasonal aeroallergens;
  • Upper airway infections in the previous 4 weeks;
  • Active smoker;
  • +15 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council

Palermo, Sicily, 90146, Italy

Location

Related Publications (1)

  • Cilluffo G, Zicari AM, Ferrante G, Malizia V, Fasola S, Duse M, De Castro G, De Vittori V, Schiavi L, Brindisi G, Petrelli P, La Grutta S. Assessing repeatability and reproducibility of Anterior Active Rhinomanometry (AAR) in children. BMC Med Res Methodol. 2020 Apr 17;20(1):86. doi: 10.1186/s12874-020-00969-1.

MeSH Terms

Conditions

RhinitisRhinitis, AllergicRhinitis, Allergic, SeasonalRhinitis, Allergic, Perennial

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsNose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.D. Senior Researcher. Coordinator of Pediatric Allergy and Asthma Research Group. Institute of Biomedicine and Molecular Immunology, IBIM, National Research Council of Palermo, Italy.

Study Record Dates

First Submitted

September 5, 2017

First Posted

September 18, 2017

Study Start

January 10, 2018

Primary Completion

July 31, 2018

Study Completion

July 31, 2018

Last Updated

November 16, 2018

Record last verified: 2018-11

Locations